ZAI LAB LIMITED

ZLAB ·Healthcare, Drug Manufacturers - General
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Assets
Cash & Equivalents $630.0M $650.8M $790.2M $788.8M $859.2M $879.8M $1.01B $1.12B
Accounts Receivable $69.6M $60.4M $59.2M $41.6M $47.3M $43.3M $40.0M $27.7M
Inventory $41.8M $37.9M $44.8M $44.2M $36.4M $38.4M $31.6M $29.1M
Total Current Assets $869.9M $888.6M $939.6M $959.7M $1.02B $1.07B $1.12B $1.21B
Property, Plant & Equipment $50.6M $52.4M $53.7M $55.3M $56.4M $58.3M $57.9M $50.5M
Goodwill
Intangible Assets (Excl. Goodwill) $44.1M $12.4M $13.4M $1.6M $1.7M $1.5M $1.5M $1.5M
Total Assets $987.4M $988.4M $1.04B $1.04B $1.11B $1.17B $1.22B $1.30B
Liabilities
Accounts Payable $127.3M $88.1M $113.0M $55.0M $67.0M $66.4M $66.0M $90.1M
Total Current Liabilities $251.7M $192.1M $203.1M $124.9M $133.4M $124.6M $139.8M $155.5M
Long-Term Debt
Total Liabilities $283.2M $226.3M $240.2M $162.7M $174.1M $168.8M $174.5M $192.6M
Stockholders' Equity
Retained Earnings $-2.33B $-2.25B $-2.20B $-2.10B $-2.03B $-1.91B $-1.86B $-1.80B
Total Stockholders' Equity $704.2M $762.2M $796.1M $881.0M $932.3M $1.00B $1.05B $1.11B
← Newer Page 2 of 3 Older →